A detailed history of Algert Global LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Algert Global LLC holds 35,487 shares of CDXS stock, worth $110,009. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,487
Previous 63,070 43.73%
Holding current value
$110,009
Previous $192,000 35.42%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$2.59 - $4.65 $71,439 - $128,260
-27,583 Reduced 43.73%
35,487 $124,000
Q4 2023

Feb 14, 2024

SELL
$1.54 - $3.37 $67,775 - $148,313
-44,010 Reduced 41.1%
63,070 $192,000
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $13,080 - $32,700
8,720 Added 8.87%
107,080 $202,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.43 $671,804 - $1.35 Million
-303,984 Reduced 75.55%
98,360 $275,000
Q1 2023

May 12, 2023

BUY
$3.81 - $6.76 $317,277 - $562,939
83,275 Added 26.1%
402,344 $1.67 Million
Q4 2022

Feb 13, 2023

BUY
$4.26 - $6.84 $110,760 - $177,840
26,000 Added 8.87%
319,069 $1.49 Million
Q3 2022

Nov 15, 2022

BUY
$6.06 - $12.86 $828,674 - $1.76 Million
136,745 Added 87.48%
293,069 $1.78 Million
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $272,460 - $714,270
32,630 Added 26.38%
156,324 $1.64 Million
Q1 2022

May 16, 2022

BUY
$16.97 - $31.93 $1.17 Million - $2.2 Million
68,919 Added 125.82%
123,694 $2.55 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $344,198 - $561,523
-13,440 Reduced 19.7%
54,775 $1.71 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $27.99 $597,458 - $851,035
30,405 Added 80.42%
68,215 $1.59 Million
Q2 2021

Aug 13, 2021

BUY
$17.48 - $25.46 $165,570 - $241,157
9,472 Added 33.43%
37,810 $857,000
Q1 2021

May 14, 2021

BUY
$18.08 - $28.8 $512,351 - $816,134
28,338 New
28,338 $649,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $203M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.